{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T21:42:33Z","timestamp":1794260553687,"version":"4.9.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012246","name":"Priority Academic Program Development of Jiangsu Higher Education Institutions","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31770962"],"award-info":[{"award-number":["31770962"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81970318"],"award-info":[{"award-number":["81970318"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82572092"],"award-info":[{"award-number":["82572092"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.nano.2025.102865","type":"journal-article","created":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T02:26:42Z","timestamp":1759544802000},"page":"102865","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Dual-targeting exosome vaccine confers efficient protection against CVB3-induced myocarditis"],"prefix":"10.1016","volume":"70","author":[{"given":"Qinghui","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihui","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sidong","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nano.2025.102865_bb0005","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/rmv.326","article-title":"The group B coxsackieviruses and myocarditis","volume":"11","author":"Kim","year":"2001","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.nano.2025.102865_bb0010","article-title":"Vaccines against Group B coxsackieviruses and their importance","volume":"11","author":"Mone","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.nano.2025.102865_bb0015","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1586\/erv.10.89","article-title":"Nano-microparticles as immune adjuvants: correlating particle sizes and the resultant immune responses","volume":"9","author":"Oyewumi","year":"2010","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.nano.2025.102865_bb0020","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.00598","article-title":"Distinct immunologic properties of soluble versus particulate antigens","volume":"9","author":"Snapper","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.nano.2025.102865_bb0025","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.711565","article-title":"Exosome-based vaccines: history, current state, and clinical trials","volume":"12","author":"Santos","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.nano.2025.102865_bb0030","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jconrel.2015.12.027","article-title":"Melanoma growth effects on molecular clearance from tumors and biodistribution into systemic tissues versus draining lymph nodes","volume":"223","author":"Rohner","year":"2016","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2025.102865_bb0035","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/s41578-019-0110-7","article-title":"Material design for lymph node drug delivery","volume":"4","author":"Schudel","year":"2019","journal-title":"Nat Rev Mater"},{"key":"10.1016\/j.nano.2025.102865_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1748-1716.1977.tb10345.x","article-title":"Protein concentration in interstitial and lymphatic fluids from the subcutaneous tissue","volume":"99","author":"Rutili","year":"1977","journal-title":"Acta Physiol Scand"},{"key":"10.1016\/j.nano.2025.102865_bb0045","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jconrel.2020.07.046","article-title":"Lymphatic targeting by albumin-hitchhiking: applications and optimisation","volume":"327","author":"Abdallah","year":"2020","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2025.102865_bb0050","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1038\/ki.1995.178","article-title":"Charge selectivity in kidney ultrafiltration","volume":"47","author":"Comper","year":"1995","journal-title":"Kidney Int"},{"key":"10.1016\/j.nano.2025.102865_bb0055","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1152\/ajplegacy.1958.194.1.120","article-title":"Lymphatic permeability to albumin","volume":"194","author":"Patterson","year":"1958","journal-title":"Am J Physiol Leg Content"},{"key":"10.1016\/j.nano.2025.102865_bb0060","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1161\/CIRCRESAHA.116.309828","article-title":"Transcellular pathways in lymphatic endothelial cells regulate changes in solute transport by fluid stress","volume":"120","author":"Triacca","year":"2017","journal-title":"Circ Res"},{"key":"10.1016\/j.nano.2025.102865_bb0065","doi-asserted-by":"crossref","first-page":"9999","DOI":"10.1021\/acsnano.6b04268","article-title":"Blood-brain-barrier-penetrating albumin nanoparticles for biomimetic drug delivery via albumin-binding protein pathways for antiglioma therapy","volume":"10","author":"Lin","year":"2016","journal-title":"ACS Nano"},{"key":"10.1016\/j.nano.2025.102865_bb0070","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s10456-010-9170-4","article-title":"Visualizing vascular permeability and lymphatic drainage using labeled serum albumin","volume":"13","author":"Vandoorne","year":"2010","journal-title":"Angiogenesis"},{"key":"10.1016\/j.nano.2025.102865_bb0075","article-title":"Discovery of novel anti-serum albumin VHH as a building block for PK prolongation","volume":"6","author":"Chen","year":"2023","journal-title":"Antibody Ther"},{"key":"10.1016\/j.nano.2025.102865_bb0080","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jconrel.2011.09.069","article-title":"Impact of albumin on drug delivery\u2014new applications on the horizon","volume":"157","author":"Elsadek","year":"2012","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2025.102865_bb0085","doi-asserted-by":"crossref","first-page":"E6490","DOI":"10.1073\/pnas.1621240114","article-title":"Lipophilic siRNA targets albumin in situ and promotes bioavailability, tumor penetration, and carrier-free gene silencing","volume":"114","author":"Sarett","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.nano.2025.102865_bb0090","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1110\/ps.02802","article-title":"Mutational analysis of the interaction between albumin-binding domain from streptococcal protein G and human serum albumin","volume":"11","author":"Linhult","year":"2002","journal-title":"Protein Sci"},{"key":"10.1016\/j.nano.2025.102865_bb0095","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.759337","article-title":"Pharmacokinetic engineering of OX40-blocking anticalin proteins using monomeric plasma half-life extension domains","volume":"12","author":"Siegemund","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.nano.2025.102865_bb0100","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.virol.2022.12.015","article-title":"Exosome-based delivery of VP1 protein conferred enhanced resistance of mice to CVB3-induced viral myocarditis","volume":"579","author":"Zhang","year":"2023","journal-title":"Virology"},{"key":"10.1016\/j.nano.2025.102865_bb0105","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1021\/bc500529d","article-title":"DC3-decorated polyplexes for targeted gene delivery into dendritic cells","volume":"26","author":"Golani-Armon","year":"2015","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.nano.2025.102865_bb0110","doi-asserted-by":"crossref","first-page":"7425","DOI":"10.4049\/jimmunol.172.12.7425","article-title":"Peptides identified through phage display direct immunogenic antigen to dendritic cells","volume":"172","author":"Curiel","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.nano.2025.102865_bb0115","series-title":"Guide for the Care and Use of Laboratory Animals The National Academies Collection: Reports Funded by National Institutes of Health","year":"2011"},{"key":"10.1016\/j.nano.2025.102865_bb0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004838","article-title":"Group selection and contribution of minority variants during virus adaptation determines virus fitness and phenotype","volume":"11","author":"Border\u00eda","year":"2015","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.nano.2025.102865_bb0125","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/oxfordjournals.aje.a118408","article-title":"A simple method of estimating fifty per cent endpoints12","volume":"27","author":"Reed","year":"1938","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.nano.2025.102865_bb0130","doi-asserted-by":"crossref","DOI":"10.1080\/20013078.2018.1535750","article-title":"Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines","volume":"7","author":"Thery","year":"2018","journal-title":"J Extracell Vesicles"},{"key":"10.1016\/j.nano.2025.102865_bb0135","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.jconrel.2024.02.037","article-title":"Smart exosomes enhance PDAC targeted therapy","volume":"368","author":"Creeden","year":"2024","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2025.102865_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.129518","article-title":"Exosome co-delivery of a STING agonist augments immunogenicity elicited by CVB3 VP1 vaccine via promoting antigen cross-presentation of CD8 (+) DCs","volume":"261","author":"Zhang","year":"2024","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.nano.2025.102865_bb0145","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.666594","article-title":"An albumin-binding domain peptide confers enhanced immunoprotection against viral myocarditis by CVB3 VP1 vaccine","volume":"12","author":"Gao","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.nano.2025.102865_bb0150","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.jconrel.2020.07.042","article-title":"Surface functionalization of exosomes for target-specific delivery and in vivo imaging & tracking: strategies and significance","volume":"326","author":"Salunkhe","year":"2020","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2025.102865_bb0155","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2014.00682","article-title":"Unraveling the interaction between FcRn and albumin: opportunities for design of albumin-based therapeutics","volume":"5","author":"Sand","year":"2015","journal-title":"Front Immunol"},{"key":"10.1016\/j.nano.2025.102865_bb0160","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1021\/acs.biomac.7b01545","article-title":"Extending half life of H-ferritin nanoparticle by fusing albumin binding domain for doxorubicin encapsulation","volume":"19","author":"Wang","year":"2018","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.nano.2025.102865_bb0165","doi-asserted-by":"crossref","DOI":"10.1088\/0957-4484\/26\/14\/145103","article-title":"PEGylated human serum albumin (HSA) nanoparticles: preparation, characterization and quantification of the PEGylation extent","volume":"26","author":"Fahrlander","year":"2015","journal-title":"Nanotechnology"},{"key":"10.1016\/j.nano.2025.102865_bb0170","first-page":"20","article-title":"Exosomes: emerging implementation of nanotechnology for detecting and managing novel corona virus-SARS-CoV-2","volume":"17","author":"Dubey","year":"2022","journal-title":"Asian J Pharm Sci"},{"key":"10.1016\/j.nano.2025.102865_bb0175","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.it.2006.05.004","article-title":"Perspective\u2014FcRn transports albumin: relevance to immunology and medicine","volume":"27","author":"Anderson","year":"2006","journal-title":"Trends Immunol"},{"key":"10.1016\/j.nano.2025.102865_bb0180","doi-asserted-by":"crossref","first-page":"408","DOI":"10.3389\/fimmu.2014.00408","article-title":"The role of FcRn in antigen presentation","volume":"5","author":"Baker","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.nano.2025.102865_bb0185","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.colsurfb.2016.03.023","article-title":"Cationized bovine serum albumin as gene carrier: influence of specific secondary structure on DNA complexibility and gene transfection","volume":"143","author":"Du","year":"2016","journal-title":"Colloids Surf B Biointerfaces"},{"key":"10.1016\/j.nano.2025.102865_bb0190","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/s41541-024-00854-8","article-title":"FcRn regulates antigen presentation in dendritic cells downstream of DEC205-targeted vaccines","volume":"9","author":"Macri","year":"2024","journal-title":"NPJ Vaccines"}],"container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963425000668?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963425000668?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T17:54:59Z","timestamp":1778522099000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1549963425000668"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":38,"alternative-id":["S1549963425000668"],"URL":"https:\/\/doi.org\/10.1016\/j.nano.2025.102865","relation":{},"ISSN":["1549-9634"],"issn-type":[{"value":"1549-9634","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dual-targeting exosome vaccine confers efficient protection against CVB3-induced myocarditis","name":"articletitle","label":"Article Title"},{"value":"Nanomedicine: Nanotechnology, Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nano.2025.102865","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102865"}}